Sandro Roier

* Associate Director-level responsibility for scientific leadership, program strategy, budget oversight, and team development * Scientific Lead of the uropathogenic Escherichia coli (UPEC) mRNA vaccine program with budget responsibility through successful clinical preparation, including FDA- and IND-relevant development activities * Leadership, coaching, and development of up to 7 scientific team members, as well as coordination of cross-functional matrix project teams * 2 peer-reviewed publications as First Author and Corresponding Author | 1 patent family | 1 presentation at an international scientific conference * Recipient of the CureVac R&D Innovation Award 2025

* Scientific leadership of strategic R&D programs for mRNA vaccines targeting bacterial, viral, and parasitic pathogens with budget responsibility (e.g., UPEC, Rotavirus, Plasmodium falciparum) * Contribution to portfolio, innovation, and research strategy decisions at executive level, including the scientific evaluation of 19 potential vaccine indications and co-organization of a Scientific Advisory Board * Leadership, coaching, and development of up to 7 scientific team members, as well as coordination of cross-functional matrix project teams * 2 peer-reviewed First-Author publications | 1 patent family | 3 presentations or posters at international scientific conferences and professional meetings

* Scientific leadership of preclinical development programs for mRNA vaccines targeting bacterial, viral, and parasitic pathogens with budget responsibility (e.g., UPEC, Rotavirus) * Development of innovative mRNA-based vaccine concepts and preclinical evaluation strategies * Establishment of international collaborations with academic and industry partners * 2 peer-reviewed First-Author review articles | 1 patent family | 1 poster at an international scientific conference

* Scientific research on bacterial conjugation and bacterial toxins in the laboratory of Dr. Ellen L. Zechner * 2 peer-reviewed Co-Author publications

* Scientific research on bacterial outer membrane vesicles in the laboratory of Dr. Stefan Schild * 1 peer-reviewed First-Author publication | 1 peer-reviewed First-Author review article

* 6 years of scientific research in microbiology, bacterial pathogenesis, and host-microbe interactions through PhD, Master's, and research project work * Use of Haemophilus influenzae, Klebsiella oxytoca, Vibrio cholerae, Escherichia coli, Pasteurella multocida, and Mannheimia haemolytica as bacterial model systems * Research stays at the University of Alberta (Edmonton, Canada) and establishment of international scientific networks and collaborations * 3 peer-reviewed First-Author publications | 7 peer-reviewed Co-Author publications | 1 patent family | 5 presentations or posters at scientific conferences and professional meetings

PhD thesis: Characterization of bacterial outer membrane vesicles and their potential as vaccine candidates against Pasteurellaceae infections

Master's thesis: Studies on outer membrane and outer membrane vesicles of Haemophilus influenzae for vaccine development

Bachelor's thesis I: Antibiotic resistance plasmids Bachelor's thesis II: Usage of transgenic plants for production of edible vaccines

Modern Management - Project Management Project management methods and techniques | risk management | quality management | project financing | project controlling | business communication | crisis management | multi-project management | project teams & team leadership | project work | business English

Introductory Course into Laboratory Animal Science - In theory, applied and in accordance with the animal protection laws (FELASA, category B)